JP2025507372A5 - - Google Patents

Info

Publication number
JP2025507372A5
JP2025507372A5 JP2024547599A JP2024547599A JP2025507372A5 JP 2025507372 A5 JP2025507372 A5 JP 2025507372A5 JP 2024547599 A JP2024547599 A JP 2024547599A JP 2024547599 A JP2024547599 A JP 2024547599A JP 2025507372 A5 JP2025507372 A5 JP 2025507372A5
Authority
JP
Japan
Application number
JP2024547599A
Other languages
Japanese (ja)
Other versions
JP2025507372A (ja
JPWO2023154900A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/062440 external-priority patent/WO2023154900A2/en
Publication of JP2025507372A publication Critical patent/JP2025507372A/ja
Publication of JP2025507372A5 publication Critical patent/JP2025507372A5/ja
Publication of JPWO2023154900A5 publication Critical patent/JPWO2023154900A5/ja
Pending legal-status Critical Current

Links

JP2024547599A 2022-02-11 2023-02-10 微小管関連タンパク質タウ(MAPT)iRNA剤組成物およびその使用方法 Pending JP2025507372A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263309399P 2022-02-11 2022-02-11
US63/309,399 2022-02-11
US202263322618P 2022-03-22 2022-03-22
US63/322,618 2022-03-22
PCT/US2023/062440 WO2023154900A2 (en) 2022-02-11 2023-02-10 Microtubule associated protein tau (mapt) irna agent compositions and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2025507372A JP2025507372A (ja) 2025-03-18
JP2025507372A5 true JP2025507372A5 (https=) 2026-02-17
JPWO2023154900A5 JPWO2023154900A5 (https=) 2026-02-17

Family

ID=87565165

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547599A Pending JP2025507372A (ja) 2022-02-11 2023-02-10 微小管関連タンパク質タウ(MAPT)iRNA剤組成物およびその使用方法

Country Status (4)

Country Link
US (1) US20250171777A1 (https=)
EP (1) EP4476338A2 (https=)
JP (1) JP2025507372A (https=)
WO (1) WO2023154900A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12551569B2 (en) 2024-03-31 2026-02-17 Arrowhead Pharmaceuticals, Inc. RNAi agents for inhibiting expression of microtubule associated protein tau (MAPT), compositions thereof, and methods of use
WO2026048822A1 (ja) * 2024-08-30 2026-03-05 東亞合成株式会社 Mapt rna配列に基づく新規二本鎖rna及びその利用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008124066A1 (en) 2007-04-05 2008-10-16 The J. David Gladstone Institutes Agents that reduce neuronal overexcitation
EP3274456B1 (en) 2015-03-25 2020-06-24 Università Degli Studi Di Trento Rna interference mediated therapy for neurodegenerative diseases
AU2021246024A1 (en) * 2020-03-30 2022-10-27 Alnylam Pharmaceuticals, Inc. Microtubule associated protein Tau (MAPT) iRNA agent compositions and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2025507372A5 (https=)
BR202022000931U2 (https=)
CN307045258S (https=)
CN307044326S (https=)
BY13170U (https=)
BY13169U (https=)
BY13168U (https=)
BY13167U (https=)
BY13166U (https=)
BY13165U (https=)
BY13164U (https=)
BY13163U (https=)
BY13162U (https=)
BY13161U (https=)
BY13160U (https=)
CN307049606S (https=)
BY13159U (https=)
CN307049142S (https=)
CN307047763S (https=)
BY13158U (https=)
CN307047758S (https=)
CN307047661S (https=)
CN307047529S (https=)
BY13157U (https=)
CN307046855S (https=)